Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 4
2016 1
2017 2
2018 4
2020 1
2021 1
2023 2
2024 3
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study.
Gisslinger H, Klade C, Georgiev P, Krochmalczyk D, Gercheva-Kyuchukova L, Egyed M, Rossiev V, Dulicek P, Illes A, Pylypenko H, Sivcheva L, Mayer J, Yablokova V, Krejcy K, Grohmann-Izay B, Hasselbalch HC, Kralovics R, Kiladjian JJ; PROUD-PV Study Group. Gisslinger H, et al. Lancet Haematol. 2020 Mar;7(3):e196-e208. doi: 10.1016/S2352-3026(19)30236-4. Epub 2020 Jan 31. Lancet Haematol. 2020. PMID: 32014125 Clinical Trial.
A Review of FLT3 Kinase Inhibitors in AML.
Negotei C, Colita A, Mitu I, Lupu AR, Lapadat ME, Popovici CE, Crainicu M, Stanca O, Berbec NM. Negotei C, et al. Among authors: berbec nm. J Clin Med. 2023 Oct 10;12(20):6429. doi: 10.3390/jcm12206429. J Clin Med. 2023. PMID: 37892567 Free PMC article. Review.
Dominance of mutations in epigenetic regulators and a diversity of signaling alterations in blast-phase BCR::ABL1-negative myeloproliferative neoplasms.
Gurban P, Mambet C, Botezatu A, Necula LG, Matei L, Neagu AI, Pitica I, Ataman M, Tatic A, Bardas A, Gaman MA, Dobrea C, Dragomir M, Ghimici C, Angelescu S, Barbu D, Stanca O, Danila M, Berbec N, Colita A, Vladareanu AM, Nedeianu S, Chivu-Economescu M, Bleotu C, Coriu D, Sepulchre E, Anton G, Diaconu CC, Constantinescu SN. Gurban P, et al. Among authors: berbec n. Am J Hematol. 2025 Jan;100(1):168-171. doi: 10.1002/ajh.27503. Epub 2024 Oct 19. Am J Hematol. 2025. PMID: 39425629 No abstract available.
Cooccurring JAK2 V617F and R1063H mutations increase JAK2 signaling and neutrophilia in myeloproliferative neoplasms.
Mambet C, Babosova O, Defour JP, Leroy E, Necula L, Stanca O, Tatic A, Berbec N, Coriu D, Belickova M, Kralova B, Lanikova L, Vesela J, Pecquet C, Saussoy P, Havelange V, Diaconu CC, Divoky V, Constantinescu SN. Mambet C, et al. Among authors: berbec n. Blood. 2018 Dec 20;132(25):2695-2699. doi: 10.1182/blood-2018-04-843060. Epub 2018 Oct 30. Blood. 2018. PMID: 30377194 Free article. No abstract available.
Delineation of Molecular Lesions in Acute Myeloid Leukemia Patients at Diagnosis: Integrated Next Generation Sequencing and Cytogenomic Studies.
Papuc SM, Erbescu A, Cisleanu D, Ozunu D, Enache C, Dumitru I, Lupoaia Andrus E, Gaman M, Popov VM, Dobre M, Stanca O, Angelescu S, Berbec N, Colita A, Vladareanu AM, Bumbea H, Arghir A. Papuc SM, et al. Among authors: berbec n. Genes (Basel). 2021 May 30;12(6):846. doi: 10.3390/genes12060846. Genes (Basel). 2021. PMID: 34070898 Free PMC article.
21 results